Omeros reported $-22703000 in Pre-Tax Profit for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Acelrx Pharmaceuticals ACRX:US $ -8.38M 1.47M
Adamas Pharmaceuticals ADMS:US -19518000 7.17M
Adma Biologics ADMA:US $ -17.71M 0.39M
Aerie Pharmaceuticals AERI:US $ -33.31M 2.2M
Alexion Pharmaceuticals ALXN:US $ 940.1M 164.6M
Alnylam Pharmaceuticals ALNY:US $ -212.93M 24.6M
Cytokinetics CYTK:US $ -76.09M 14.53M
Five Prime Therapeutics FPRX:US $ -20.85M 0M
Insmed INSM:US $ -115292000 1.41M
Intercept Pharmaceuticals ICPT:US $ -3.63M 7.46M
Knight Therapeutics Inc GUD:CN C$ -9888000 36.46M
Macrogenics MGNX:US $ -52.89M 12.95M
Mirati Therapeutics MRTX:US $ -76.76M 89.68M
Omeros OMER:US $ -22703000 5.89M
Regulus Therapeutics RGLS:US $ -8.63M 2.6M
Rockwell Medical RMTI:US $ -7.58M 0.82M
Sangamo Biosciences SGMO:US $ -47.6M 0.45M
Sarepta Therapeutics SRPT:US $ -47.91M 33.85M
United Therapeutics UTHR:US $ 204.4M 12.1M
Vital Therapies VTL:US $ -19.29M 1.36M
Xoma XOMA:US $ -4.44M 2.2M